mortality/aging
• most mutants die by 24 weeks of age
|
behavior/neurological
• motor dysfunction occurs at about 20 weeks of age
• mutants treated with recombinant human LGALS1 (GAL1) show alleviation of disease symptoms, with mice surviving longer, showing improved motor function and improved motor neuron survival
|
• mutants fall off the rotarod within 420 seconds with onset of disease, starting at around 138 day of age
|
muscle
• progressive muscle wasting in the limbs, leading to death due to inability to reach the water supply
|
• mutants first present with weakness in hindlimbs, as indicated by dragging of one limb
|
nervous system
• eosinophilic inclusion bodies similar to Lewy body-like hyaline inclusions in human amyotrophic lateral sclerosis are seen in the anterior horns
• however, mutants do not exhibit any remarkable vacuoles in cell bodies, dendrites or axons
|
• neurite swellings are seen in the anterior horn by 147 days of age
• severe decrease in the number of anterior horn neurons with diffuse astrocytic proliferation is seen at the end of life
|
• at 119 days of age (late presymptomatic stage), large anterior horn cells are decreased in number, with a marked loss of these cells by 147 days of age
|
• astrocytic proliferation is seen by 147 day s of age in the anterior horn
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
amyotrophic lateral sclerosis type 1 | DOID:0060193 |
OMIM:105400 |
J:99701 |